Oxygenta Pharmaceutical Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Sep 2024 | Jun 2024 | Mar 2024 |
|---|---|---|---|
| Revenue | 14.75 | 12.64 | 10.81 |
| Operating Expense | 16.18 | 14.40 | 12.17 |
| Net Profit | -2.85 | -1.36 | 8.02 |
| Net Profit Margin | -19.32 | -10.76 | 74.19 |
| Earning Per Share | -0.81 | -0.39 | 2.55 |
| EBIDTA | -1.50 | -0.30 | 9.25 |
| Effective Tax Rate | TBA | TBA | TBA |
| Particulars | Sep 2024 |
|---|---|
| Revenue | 14.75 |
| Operating Expense | 16.18 |
| Net Profit | -2.85 |
| Net Profit Margin | -19.32 |
| Earning Per Share | -0.81 |
| EBIDTA | -1.50 |
| Effective Tax Rate | TBA |
Invest in Oxygenta Pharmaceutical Ltd
₹0 Brokerage*
Open Demat Account
*By signing up you agree to our Terms and Conditions
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Total Revenue Annual | 39.64 | 30.99 | 60.52 |
| Operating Expenses Annual | 49.34 | 38.10 | 59.05 |
| Operating Profit Annual | -9.62 | -7.83 | 2.03 |
| Interest Annual | 1.59 | 1.49 | 0.92 |
| Depreciation | 2.66 | 2.05 | 1.59 |
| Net Profit Annual | -3.48 | -11.57 | -0.61 |
| Tax Annual | -10.39 | 0.20 | 0.12 |
| Particulars | Mar 2024 |
|---|---|
| Total Revenue Annual | 39.64 |
| Operating Expenses Annual | 49.34 |
| Operating Profit Annual | -9.62 |
| Interest Annual | 1.59 |
| Depreciation | 2.66 |
| Net Profit Annual | -3.48 |
| Tax Annual | -10.39 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Cash Flow at the Beginning | 0.11 | 0.16 | 0.45 |
| Cash Flow from Operations | -13.05 | -1.63 | -1.68 |
| Cash Flow from Investing | -4.09 | -9.64 | -4.94 |
| Cash Flow from Financing | 17.13 | 11.22 | 6.33 |
| Cash Flow at the End | 0.10 | 0.11 | 0.16 |
| Particulars | Mar 2024 |
|---|---|
| Cash Flow at the Beginning | 0.11 |
| Cash Flow from Operations | -13.05 |
| Cash Flow from Investing | -4.09 |
| Cash Flow from Financing | 17.13 |
| Cash Flow at the End | 0.10 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| PBDIT Margin (%) | -24.27 | -25.27 | 2.43 |
| PBIT Margin (%) | -30.98 | -31.88 | -0.20 |
| PBT Margin (%) | -11.50 | -10.49 | 0.01 |
| Net PROFIT Margin (%) | -8.78 | -37.33 | -1.01 |
| Return On Networth / Equity (%) | TBA | TBA | TBA |
| Return On Networth /Employed (%) | TBA | TBA | TBA |
| Return On Assets (%) | -10.97 | -48.16 | -3.00 |
| Total Debt / Equity (X) | TBA | TBA | TBA |
| Asset Turnover Ratio (%) | 1.25 | 1.29 | 2.98 |
| Particulars | Mar 2024 |
|---|---|
| PBDIT Margin (%) | -24.27 |
| PBIT Margin (%) | -30.98 |
| PBT Margin (%) | -11.50 |
| Net PROFIT Margin (%) | -8.78 |
| Return On Networth / Equity (%) | TBA |
| Return On Networth /Employed (%) | TBA |
| Return On Assets (%) | -10.97 |
| Total Debt / Equity (X) | TBA |
| Asset Turnover Ratio (%) | 1.25 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Fixed Assets Annual | 29.36 | 27.91 | 19.98 |
| Total Current Assets Annual | 24.11 | 25.01 | 9.56 |
| Non Current Assets Annual | 39.09 | 29.26 | 21.61 |
| Total Shareholders Funds Annual | -20.12 | -46.20 | -34.63 |
| Total Assets Annual | 63.19 | 54.26 | 31.18 |
| Particulars | Mar 2024 |
|---|---|
| Fixed Assets Annual | 29.36 |
| Total Current Assets Annual | 24.11 |
| Non Current Assets Annual | 39.09 |
| Total Shareholders Funds Annual | -20.12 |
| Total Assets Annual | 63.19 |
No Data Availabe
